JPS6013793A - 結晶性７−（ｒ）−アミノ−３−（１−ピリジニウムメチル）−３−セフエム−４−カルボキシレ−ト・一塩酸塩・一水和物 - Google Patents

結晶性７−（ｒ）−アミノ−３−（１−ピリジニウムメチル）−３−セフエム−４−カルボキシレ−ト・一塩酸塩・一水和物

Info

Publication number
JPS6013793A
JPS6013793A JP59123554A JP12355484A JPS6013793A JP S6013793 A JPS6013793 A JP S6013793A JP 59123554 A JP59123554 A JP 59123554A JP 12355484 A JP12355484 A JP 12355484A JP S6013793 A JPS6013793 A JP S6013793A
Authority
JP
Japan
Prior art keywords
cephem
amino
carboxylate
pyridiniummethyl
crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP59123554A
Other languages
English (en)
Japanese (ja)
Inventor
プレストン・シ−・コンラツド
アルビダス・エイ・ジヤ−マス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of JPS6013793A publication Critical patent/JPS6013793A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/18—7-Aminocephalosporanic or substituted 7-aminocephalosporanic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
JP59123554A 1983-06-20 1984-06-14 結晶性７−（ｒ）−アミノ−３−（１−ピリジニウムメチル）−３−セフエム−４−カルボキシレ−ト・一塩酸塩・一水和物 Pending JPS6013793A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/505,662 US4540779A (en) 1983-06-20 1983-06-20 Crystalline 7-(R)-amino-3-(1'pyridiniummethyl)-ceph-3-em-4-carboxylate monohydrochloride monohydrate compound
US505662 1983-06-20

Publications (1)

Publication Number Publication Date
JPS6013793A true JPS6013793A (ja) 1985-01-24

Family

ID=24011278

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59123554A Pending JPS6013793A (ja) 1983-06-20 1984-06-14 結晶性７−（ｒ）−アミノ−３−（１−ピリジニウムメチル）−３−セフエム−４−カルボキシレ−ト・一塩酸塩・一水和物

Country Status (12)

Country Link
US (1) US4540779A (en, 2012)
EP (1) EP0135258B1 (en, 2012)
JP (1) JPS6013793A (en, 2012)
KR (1) KR870000327B1 (en, 2012)
CA (1) CA1216577A (en, 2012)
DE (1) DE3479659D1 (en, 2012)
DK (1) DK166388C (en, 2012)
GB (1) GB2141715B (en, 2012)
GR (1) GR82375B (en, 2012)
HU (1) HU192558B (en, 2012)
IE (1) IE57622B1 (en, 2012)
IL (1) IL72103A (en, 2012)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61200994A (ja) * 1985-03-01 1986-09-05 Dai Ichi Seiyaku Co Ltd ３−ピリジニウムメチルセフエム誘導体
JPS62108883A (ja) * 1985-11-06 1987-05-20 イ−ライ・リリ−・アンド・カンパニ− 結晶性セフアロスポリン・一水和物
US4959469A (en) * 1984-12-27 1990-09-25 Banyu Pharmaceutical Company, Ltd. Crystalline cephalosporin compounds

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60169486A (ja) * 1984-02-10 1985-09-02 Yamanouchi Pharmaceut Co Ltd ７−アミノ−３−置換メチル−３−セフエム−４−カルボン酸およびその低級アルキルシリル誘導体の製造法
US4714760A (en) * 1985-08-20 1987-12-22 Bristol-Myers Company Cephalosporin intermediates
DE10155242A1 (de) * 2001-11-09 2003-05-22 Bayer Ag Herstellung von Polyamid
CN109134499A (zh) * 2018-10-10 2019-01-04 河北鸿旭翔药业有限公司 7-氨基-3-（1-吡啶甲基）头孢烯酸氯化物及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5612397A (en) * 1979-05-25 1981-02-06 Glaxo Group Ltd Intermediate for manufacture of cephalosporin antibiotic

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB953695A (en) * 1959-08-04 1964-03-25 Nat Res Dev Derivatives of cephalosporin c
AR229883A1 (es) * 1978-05-26 1983-12-30 Glaxo Group Ltd Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5612397A (en) * 1979-05-25 1981-02-06 Glaxo Group Ltd Intermediate for manufacture of cephalosporin antibiotic

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4959469A (en) * 1984-12-27 1990-09-25 Banyu Pharmaceutical Company, Ltd. Crystalline cephalosporin compounds
JPS61200994A (ja) * 1985-03-01 1986-09-05 Dai Ichi Seiyaku Co Ltd ３−ピリジニウムメチルセフエム誘導体
JPS62108883A (ja) * 1985-11-06 1987-05-20 イ−ライ・リリ−・アンド・カンパニ− 結晶性セフアロスポリン・一水和物

Also Published As

Publication number Publication date
GB8415508D0 (en) 1984-07-25
EP0135258B1 (en) 1989-09-06
DE3479659D1 (en) 1989-10-12
IE841505L (en) 1984-12-20
IL72103A (en) 1987-12-20
CA1216577A (en) 1987-01-13
IL72103A0 (en) 1984-10-31
DK297284D0 (da) 1984-06-18
DK166388C (da) 1993-09-27
GR82375B (en, 2012) 1984-12-13
IE57622B1 (en) 1993-02-10
GB2141715B (en) 1986-12-10
HUT34756A (en) 1985-04-28
US4540779A (en) 1985-09-10
DK297284A (da) 1984-12-21
EP0135258A3 (en) 1985-12-18
KR870000327B1 (ko) 1987-02-27
DK166388B (da) 1993-05-10
GB2141715A (en) 1985-01-03
KR850000459A (ko) 1985-02-27
HU192558B (en) 1987-06-29
EP0135258A2 (en) 1985-03-27

Similar Documents

Publication Publication Date Title
US20070244315A1 (en) Process for the preparation of cefdinir
JPH02311483A (ja) セフトリアキソンの製造方法
CA1228851A (en) Crystalline ceftazidime salts
JPS6013793A (ja) 結晶性７−（ｒ）−アミノ−３−（１−ピリジニウムメチル）−３−セフエム−４−カルボキシレ−ト・一塩酸塩・一水和物
CS258143B2 (en) Method of crystalline solavate production
EP0113568B1 (en) Intermediates for the preparation of ceftazidine, and process for their preparation
JPS6118786A (ja) セフタジダイムの改良結晶化法
JP2003513983A (ja) 高純度セフポドキシムプロキセチルの製造方法
KR102167614B1 (ko) 가도부트롤의 제조방법
JPS6115885A (ja) セフタジイムの製造
CA1279311C (en) Crystalline cephalosporin monohydrate
US3644377A (en) Process for the preparation of (4-pyridylthio)acetic acid
CA2436265A1 (en) 3-(3-amidinophenyl)-5-[({[1-(1-iminoethyl)-4-piperidyl]methyl}amino)methyl]benzoic acid dihydrochloride and process for preparing the same
KR0156275B1 (ko) 세프타지딤 펜타하이드레이트의 제조방법
JP2662414B2 (ja) チアゾール誘導体
KR20120078687A (ko) 새로운 효소를 이용한 세팔로스포린계 항생제 중간체의 제조방법
JP3259196B2 (ja) ２−ヒドラジノ−４，６−ジメトキシピリミジンの製造法
KR100432425B1 (ko) 세펨 유도체 또는 그 염의 신규한 제조방법
JPH0356482A (ja) 光学活性な２―フタルイミドオキシーフェニル酢酸誘導体およびその製造方法
JPS5821635B2 (ja) ３− メチル −３− セフエムコウセイブツシツノ セイホウ
JPH0987256A (ja) トリアジン誘導体の製法
JPS5867698A (ja) ３−（２−ベンツイミダゾリル）チオメチル−３−セフエム誘導体およびその製造法